Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.
Andersson NW, Thiesson EM, Baum U, Pihlström N, Starrfelt J, Faksová K, Poukka E, Lund LC, Hansen CH, Aakjær M, Kjær J, Cohet C, Goossens M, Andersen M, Hallas J, Meijerink H, Ljung R, Hviid A. Andersson NW, et al. Among authors: ljung r. BMJ. 2023 Jul 24;382:e074325. doi: 10.1136/bmj-2022-074325. BMJ. 2023. PMID: 37487623 Free PMC article.
COVID-19 Vaccine Effectiveness Among Adolescents.
Poukka E, Andersson NW, Thiesson EM, Baum U, Pihlström N, Perälä J, Kristoffersen AB, Meijerink H, Starrfelt J, Ljung R, Hviid A. Poukka E, et al. Among authors: ljung r. Pediatrics. 2024 Jan 1;153(2):e2023062520. doi: 10.1542/peds.2023-062520. Pediatrics. 2024. PMID: 38196395
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.
Nunes B, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Moustsen-Helms IR, Sacco C, Fabiani M, Castilla J, Martínez-Baz I, Meijerink H, Machado A, Soares P, Ljung R, Pihlström N, Nardone A, Bacci S, Monge S; VEBIS-EHR working group. Nunes B, et al. Among authors: ljung r. Expert Rev Vaccines. 2024 Jan-Dec;23(1):1085-1090. doi: 10.1080/14760584.2024.2428800. Epub 2024 Nov 25. Expert Rev Vaccines. 2024. PMID: 39535047 Free article.
Effectiveness of JN.1 monovalent COVID-19 vaccination in EU/EEA countries between October 2024 and January 2025: a VEBIS electronic health record network study.
Humphreys J, Blake A, Nicolay N, Braeye T, Van Evercooren I, Hansen CH, Moustsen-Helms IR, Sacco C, Mateo-Urdiales A, Castilla J, Martínez-Baz I, Machado A, Brito A, Ljung R, Pihlstrom N, Mansiaux Y, Monge S, Bacci S, Nunes B; VEBIS-EHR working group. Humphreys J, et al. Among authors: ljung r. Vaccine. 2025 Oct 3;64:127752. doi: 10.1016/j.vaccine.2025.127752. Epub 2025 Sep 19. Vaccine. 2025. PMID: 40974735 Free PMC article.
Overview of approved COVID-19 vaccines in the EU, recommendations for use in Sweden and vaccine uptake over time: Report from the Swedish Medical Products Agency and the Public Health Agency of Sweden.
Zethelius B, Rubin J, Pihlström N, Liminga UW, Back H, Aronsson B, Tegnell A, Marking U, Ludvigsson JF, Andersson S, Ljung R. Zethelius B, et al. Among authors: ljung r. Ups J Med Sci. 2025 Oct 16;69. doi: 10.48101/ujms.v130.12937. eCollection 2025. Ups J Med Sci. 2025. PMID: 41189699 Free PMC article. Review.
439 results